Victory Capital Management Inc Cytokinetics Inc Transaction History

Victory Capital Management Inc

  • $95.7 Billion
  • Q4 2024

A detailed history of Victory Capital Management Inc transactions in Cytokinetics Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 21,716 shares of CYTK stock, worth $903,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,716
Previous 35,604 39.01%
Holding current value
$903,819
Previous $1.88 Million 45.66%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$46.36 - $58.62 $643,847 - $814,114
-13,888 Reduced 39.01%
21,716 $1.02 Million
Q3 2024

Nov 05, 2024
SELL
$51.22 - $60.16 $73,500 - $86,329
-1,435 Reduced 3.87%
35,604 $1.88 Million
Q2 2024

Aug 05, 2024
BUY
$47.86 - $75.05 $164,446 - $257,871
3,436 Added 10.23%
37,039 $2.01 Million
Q1 2024

May 03, 2024
SELL
$63.75 - $108.06 $10.1 Million - $17.1 Million
-158,051 Reduced 82.47%
33,603 $2.36 Million
Q4 2023

Feb 05, 2024
BUY
$26.88 - $83.49 $4.7 Million - $14.6 Million
174,848 Added 1040.39%
191,654 $16 Million
Q3 2023

Nov 06, 2023
BUY
$29.46 - $36.61 $32,140 - $39,941
1,091 Added 6.94%
16,806 $495,000
Q2 2023

Jul 27, 2023
BUY
$32.62 - $40.75 $10,438 - $13,040
320 Added 2.08%
15,715 $512,000
Q1 2023

May 02, 2023
SELL
$33.36 - $45.71 $2.34 Million - $3.2 Million
-70,037 Reduced 81.98%
15,395 $541,000
Q4 2022

Feb 10, 2023
BUY
$35.77 - $51.11 $572,892 - $818,577
16,016 Added 23.07%
85,432 $3.91 Million
Q4 2022

Feb 09, 2023
SELL
$35.77 - $51.11 $19 Million - $27.1 Million
-529,812 Reduced 88.42%
69,416 $3.18 Million
Q3 2022

Nov 02, 2022
BUY
$38.54 - $54.52 $20.2 Million - $28.5 Million
523,279 Added 688.99%
599,228 $29 Million
Q2 2022

Aug 01, 2022
BUY
$33.93 - $48.92 $1.79 Million - $2.59 Million
52,886 Added 229.31%
75,949 $2.98 Million
Q1 2022

May 04, 2022
BUY
$29.74 - $46.0 $428,196 - $662,308
14,398 Added 166.16%
23,063 $920,000
Q4 2021

Feb 07, 2022
SELL
$34.35 - $46.38 $37,991 - $51,296
-1,106 Reduced 11.32%
8,665 $395,000
Q3 2021

Nov 02, 2021
BUY
$18.54 - $35.74 $181,154 - $349,215
9,771 New
9,771 $349,000
Q2 2021

Aug 03, 2021
SELL
$19.79 - $26.99 $196,574 - $268,091
-9,933 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$18.57 - $25.68 $184,455 - $255,079
9,933 New
9,933 $231,000
Q2 2020

Aug 07, 2020
SELL
$11.15 - $24.64 $90,147 - $199,214
-8,085 Closed
0 $0
Q1 2020

May 04, 2020
SELL
$8.75 - $16.3 $28,752 - $53,561
-3,286 Reduced 28.9%
8,085 $95,000
Q4 2019

Feb 06, 2020
BUY
$7.95 - $11.84 $24,652 - $36,715
3,101 Added 37.5%
11,371 $121,000
Q4 2019

Feb 04, 2020
SELL
$7.95 - $11.84 $349 - $520
-44 Reduced 0.53%
8,270 $102,000
Q3 2019

Nov 12, 2019
BUY
$10.82 - $14.25 $89,957 - $118,474
8,314 New
8,314 $95,000

Others Institutions Holding CYTK

# of Institutions
416
Shares Held
128M
Call Options Held
4.57M
Put Options Held
2.42M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.92B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email